Jiangsu Hengrui ribupatide injection marketing application accepted in China
Jiangsu Hengrui Pharmaceuticals Co Ltd said its ribupatide injection marketing application was accepted by China’s drug regulator.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.